31 – 40 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
A comparative in vitro evaluation of six von Willebrand factor concentrates.
(
- Contribution to journal › Article
-
Mark
Economic evaluation: what are we looking for and how do we get there?
(
- Contribution to journal › Article
-
Mark
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
(
- Contribution to journal › Article
-
Mark
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
(
- Contribution to journal › Article
- 2003
-
Mark
Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure.
(
- Contribution to journal › Article
-
Mark
Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke?
(
- Contribution to journal › Article
-
Mark
Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.
(
- Contribution to journal › Article
-
Mark
Experience with a new percutaneous port system, Percuseal(R), for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.
(
- Contribution to journal › Letter
-
Mark
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
(
- Contribution to journal › Article